ConductScience.org, home

Paper5322320

Studies of the dependence-producing potential of the narcotic antagonist 2-cyclopropylmethyl-2'-hydroxy-5,9-dimethyl-6,7-benzomorphan (cyclazocine, WIN-20,740, ARC II-c-3).

Martin WR and 3 others. J Pharmacol Exp Ther, 1965. Cited by 147 papers, by iCite.

Cite this record

ConductScience Library. Studies of the dependence-producing potential of the narcotic antagonist 2-cyclopropylmethyl-2'-hydroxy-5,9-dimethyl-6,7-benzomorphan (cyclazocine, WIN-20,740, ARC II-c-3). Papers, record 5322320. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5322320

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Studies of the dependence-producing potential of the narcotic antagonist 2-cyclopropylmethyl-2'-hydroxy-5,9-dimethyl-6,7-benzomorphan (cyclazocine, WIN-20,740, ARC II-c-3).
PubMed
Journal
J Pharmacol Exp Ther
PubMed
Year
1965
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article
PubMed
Citations, by iCite
147
iCite
Revised in PubMed
2013-11-21
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Martin WRW R
2Fraser HFH F
3Gorodetzky CWC W
4Rosenberg DED E

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AnalgesicsMajor topic
Narcotic AntagonistsMajor topic
Substance-Related DisordersMajor topic
Amphetamine
Barbiturates
Cannabis
Clinical Trials as Topic
Cocaine
Cyclazocine
Drug Tolerance
Euphoria
Humans
Morphine
Nalorphine
Pupil
Substance Withdrawal Syndrome

Source PubMed

Download CSV of topics

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 147 citations.

PMIDTitleJournalYearIn PapersSource
41083597Kappa opioid receptor control of motivated behavior revisited.Neuropsychopharmacology2026https://conductscience.org/library/papers/41083597PubMed
26075331Ketamine and phencyclidine: the good, the bad and the unexpected.Br J Pharmacol2015https://conductscience.org/library/papers/26075331PubMed
23548164Neoclerodanes as atypical opioid receptor ligands.J Med Chem2013https://conductscience.org/library/papers/23548164PubMed
23086943Ligand directed signaling differences between rodent and human κ-opioid receptors.J Biol Chem2012https://conductscience.org/library/papers/23086943PubMed
20791310Computers in medicine: bibliography on cannabis: a medlars search.Br Med J1967https://conductscience.org/library/papers/20791310PubMed
20372880Kappa opioids and the modulation of pain.Psychopharmacology (Berl)2010https://conductscience.org/library/papers/20372880PubMed
8947927Cyclazocine revisited.Neurochem Res1996https://conductscience.org/library/papers/8947927PubMed
6779335Drug preference and mood in humans: d-amphetamine.Psychopharmacology (Berl)1980https://conductscience.org/library/papers/6779335PubMed
6440178Behavioral effects of cyclazocine on rats assessed in the open field and residential maze.Psychopharmacology (Berl)1984https://conductscience.org/library/papers/6440178PubMed
5970903Agonist and antagonist actions of morphine-like drugs on the guinea-pig isolated ileum.Br J Pharmacol Chemother1966https://conductscience.org/library/papers/5970903PubMed
5664147Kinetic parameters of narcotic agonists and antagonists, with particular reference to N-allylnoroxymorphone (naloxone).Br J Pharmacol Chemother1968https://conductscience.org/library/papers/5664147PubMed
5472208Quantitative studies on the antagonism by naloxone of some narcotic and narcotic-antagonist analgesics.Br J Pharmacol1970https://conductscience.org/library/papers/5472208PubMed
5051460A correlative evaluation of cyclazocine, LSD and naloxone on continuous discriminated avoidance in rats.Psychopharmacologia1972https://conductscience.org/library/papers/5051460PubMed
4923522Subjective effects of narcotic antagonists cyclazocine and nalorphine on the Addiction Research Center Inventory (ARCI).Psychopharmacologia1970https://conductscience.org/library/papers/4923522PubMed
4389201Effects of opiates and opiate antagonists on the Straub tail reaction in mice.Br J Pharmacol1969https://conductscience.org/library/papers/4389201PubMed
2827830Pharmacological profile of PD 117302, a selective kappa-opioid agonist.Br J Pharmacol1987https://conductscience.org/library/papers/2827830PubMed
826950Blockade of the discriminative effects of morphine in the rat by naltrexone and naloxone.Psychopharmacology (Berl)1976https://conductscience.org/library/papers/826950PubMed
823558Assessment of morphine-type physical dependence liability: a screening method using the rat.Psychopharmacology (Berl)1976https://conductscience.org/library/papers/823558PubMed
465291Human pharmacology of narcotic antagonists.Br J Clin Pharmacol1979https://conductscience.org/library/papers/465291PubMed
380616History and development of mixed opioid agonists, partial agonists and antagonists.Br J Clin Pharmacol1979https://conductscience.org/library/papers/380616PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5322320

GET https://conductscience.org/api/papers/v1/5322320/cited_by?page=2